Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Palliative care for patients with end-stage liver disease.

Larson AM.

Curr Gastroenterol Rep. 2015 May;17(5):440. doi: 10.1007/s11894-015-0440-6.

PMID:
25855211
2.

Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.

Walling AM, Schreibeis-Baum H, Pimstone N, Asch SM, Robinson L, Korlekar S, Lorenz K, Nwajuaku T, Rosenfeld K.

J Palliat Med. 2015 Apr;18(4):378-81. doi: 10.1089/jpm.2014.0265. Epub 2014 Dec 10.

PMID:
25493552
3.

Integration of palliative care in end-stage liver disease and liver transplantation.

Potosek J, Curry M, Buss M, Chittenden E.

J Palliat Med. 2014 Nov;17(11):1271-7. doi: 10.1089/jpm.2013.0167. Review.

PMID:
25390468
4.

Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study.

Alsina AE, Makris A, Nenos V, Sucre E, Arrobas J, Franco E, Kemmer N.

Am Surg. 2014 Jul;80(7):680-4.

PMID:
24987900
5.

Advances in management and prognostication in critically ill cirrhotic patients.

Karvellas CJ, Bagshaw SM.

Curr Opin Crit Care. 2014 Apr;20(2):210-7. doi: 10.1097/MCC.0000000000000067. Review.

PMID:
24514101
6.

Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management.

Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):692-8. doi: 10.1016/j.cgh.2013.08.027. Epub 2013 Aug 24.

PMID:
23978345
7.

Liver transplantation after stage II palliation for hypoplastic left heart syndrome.

Feier FH, Neto JS, Porta G, Fonseca EA, Vincenzi R, Cândido HL, Benavides M, Ketzer B, Pugliese R, Miura IK, Baggio V, Guimarães T, Porta A, Foronda G, Donizete E, da Silva JP, Faria L, Kondo M, Chapchap P.

Liver Transpl. 2013 Mar;19(3):322-7. doi: 10.1002/lt.23593.

8.

Underutilization of therapy for hepatocellular carcinoma in the medicare population.

Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF.

Cancer. 2011 Mar 1;117(5):1019-26. doi: 10.1002/cncr.25683. Epub 2010 Oct 13.

9.

The role of basic nutritional research in pediatric liver disease: An historical perspective.

Cleghorn G.

J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S93-6. doi: 10.1111/j.1440-1746.2009.06078.x. Review.

PMID:
19799706
10.
11.

Palliative care for patients with end-stage liver disease ineligible for liver transplantation.

Sanchez W, Talwalkar JA.

Gastroenterol Clin North Am. 2006 Mar;35(1):201-19. Review.

PMID:
16530121
12.

Treatment of hepatocellular carcinoma: is there an optimal strategy?

Varela M, Sala M, Llovet JM, Bruix J.

Cancer Treat Rev. 2003 Apr;29(2):99-104. Review.

PMID:
12670452
13.

Polycystic kidney disease: etiology, pathogenesis, and treatment.

Martinez JR, Grantham JJ.

Dis Mon. 1995 Nov;41(11):693-765. Review.

PMID:
7587886
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk